
HQ - Watham
Summary
Kailera Therapeutics is a clinical-stage biopharmaceutical company focused on advancing a differentiated, late-stage portfolio of next-generation therapies for the treatment of obesity.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
Senior Management
Ron Renaud
CEO
Maura Gavaghan
Vice President, Corporate Communications and Investor Relations